Contact manufacturing
Global market analysis tells you which markets your formula can enter, what has to change for each, and the order that costs least. We compare TGA, FDA and UAE rules for your exact product and give you a written market entry order before you spend on labels or stock.
Markets
AU · US · UAE
Timeline
From 2 weeks
You receive
A written market entry order
Three questions. We show the services your next market will need.
Starting from this service
Your pathway
Question 1 of 3
What this covers
Selling one supplement in several markets is rarely a matter of translating the label. An ingredient permitted in an Australian listed medicine may need an NDI notification in the US. A dose that is routine under DSHEA may be above what the TGA allows. A claim that works in Los Angeles may be a breach in Sydney. The analysis finds those differences before they cost you a reprint or a recall.
We take your formula, your claims and your commercial plan and test them against each market you are considering. For every market you get the regulatory route, the changes the formula or label would need, the evidence you would have to hold, and a realistic cost and timeline. Then we recommend an order of entry, usually the one that lets later markets reuse the most work from earlier ones.
Most of our clients are Australian brands moving into the US, or US brands entering Australia, and increasingly the UAE. We also look at whether one label can serve several markets, or whether separate artwork is the cheaper choice over time.
The analysis is written for decisions, not for a shelf. Each market is scored on the work it needs, the evidence it requires and the time it takes, so you can see at a glance why we recommend one order over another. If your plans change, the analysis gives you a clear basis to change the order without starting again.
DSHEA status for every ingredient, with NDI questions flagged.
Panel, statement of identity and required label copy, laid out for your designer.
Claims, substantiation and the 30-day FDA notification.
Website, ads and marketplace listings checked against FDA and FTC rules.
Supplier and manufacturer paperwork reviewed against 21 CFR 111.
What an FDA inspector would ask for, and where it lives.
How it works
Every Global Market Analysis scope follows the same four stages. You receive a written output at the end of each, so nothing depends on memory or a phone call.
Discovery
We learn the product, where it is sold today and how you plan to sell it in the US.
Written output: Discovery notes
Validation
Each ingredient, dose and claim is checked against DSHEA, FDA labelling rules and FTC guidance.
Written output: Validation report
Scope
We set out exactly what will be prepared, by whom, and when you will have it.
Written output: Signed scope
Build
Label, claims file, notifications and marketing review, delivered to the scope.
Written output: Final compliance file
Who this is for
Listed medicines, from single actives to complex multis.
Strain selection, stability and claim wording..
Protein, pre-workout and recovery, food or medicine.
Cognitive claims handled with care.
FSANZ standards for foods that do more.
Collagen, skin and hair from the inside.
A note from Amelia
Often scoped together
FDA and DSHEA compliance for dietary supplements and nutraceuticals.
TGA and FSANZ pathways for supplements, nutraceuticals, cosmetics and medical devices.
Product registration and labelling for the Emirates market.
Questions
If your question isn’t here, send it with your enquiry. We reply within two business days.
It is a written assessment of how your supplement would be regulated in each market you are considering, what would need to change, and what each entry would cost and take. It ends with a recommended order of entry, so you commit money to labels, stock and marketing in the right sequence.
The biggest difference is approval. In Australia most supplements are listed on the ARTG before sale and must use permitted ingredients and indications. In the US the FDA does not approve supplements, but the brand carries full responsibility for ingredients, claims and manufacturing. Permitted doses, claim wording and label layout also differ.
Often, yes, but rarely without changes. The formula may need an NDI check, the claims usually need rewriting as structure-function claims, and the label must be rebuilt around a Supplement Facts panel. We set out exactly what changes before you commit to a US launch.
Sometimes. Dual-market labels are possible when the formula, claims and required statements overlap enough. More often a shared design with market-specific panels is cheaper and safer. We compare both options for your product.
Most analyses are delivered from two weeks, depending on the number of markets and how complete your formula and evidence are when we start.
A formula that suits young adults in Sydney may not suit older adults in Los Angeles or families in Dubai. Nutrient needs, diets, cultural requirements, climate and local rules all shift from one population to the next. Here is how we approach reformulating a supplement so it fits the people who will take it.
Expanding a supplement brand into a second or third country is rarely a copy and paste job. Each market brings its own rules for ingredients, claims, labels and post-market duties. Here is how we help brands sequence their markets, build once and scale without losing control of compliance.
A compliant label does not make a compliant listing. Product pages on Amazon and Shopify carry claims, images and keywords that regulators and marketplaces treat just as seriously as your pack. Here is why your listings deserve the same review as your label, and what to check before you hit publish.
Add collagen to coffee and you might think you have made a supplement. In most cases, regulators see a food. That changes the label, the ingredients you can use and the claims you can make. Here is how classification works for functional foods in Australia and the US, and why it matters early.
Your scope
Services you add appear here and are sent with your enquiry. We reply within two business days with fixed fees.
